Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ilker, Nihat Okten"'
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSESyrian refugees (SRs) have had difficulties in the diagnosis, treatment, and follow-up of chronic diseases, such as cancer, because of the conflict in the region. The cancer diagnosis and treatment process of SR are also a matter of curiosity.
Externí odkaz:
https://doaj.org/article/280578b6c5a34e74a674ae357502f92f
Autor:
Baran Akagündüz, Deniz Can Guven, Muhammet Ozer, Ilker Nihat Okten, Elif Atag, İlkay Tugba Unek, Ali Murat Tatli, Aziz Karaoglu
Publikováno v:
Journal of Geriatric Oncology. 14:101367
In most western countries, the median age of patients with CRC is around 70 years. Although the benefit of adjuvant chemotherapy has been established in stage III colon cancer, it remains controversial in patients with stage II disease. Colon cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc2cd477a859fa0d3afc70d34284e73
https://doi.org/10.1016/j.jgo.2022.08.016
https://doi.org/10.1016/j.jgo.2022.08.016
Autor:
Mesut Seker, Serkan Celik, Bala Basak Oven, Günay Gürleyik, Fugen Aker Vardar, Ali Aktekin, Ezgi Coban, Ilker Nihat Okten
Publikováno v:
Journal of Oncological Sciences. 7:7-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce5292d5ac5811e6fa3bcb3589ccb6e4
https://doi.org/10.37047/jos.2020-75852
https://doi.org/10.37047/jos.2020-75852
Publikováno v:
Clinical Oncology and Research. :1-6
Introduction: Breast cancer is one of the most common malignancy that metastases to brain with the risk of 10-16%. Brain metastasis has been reported to be more common among younger women with tumors larger diameter and higher grade, hormone negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6151bb17f02efcd78e21af0d4ac8d3aa
https://doi.org/10.31487/j.cor.2020.06.04
https://doi.org/10.31487/j.cor.2020.06.04
Autor:
Sinan Koca, Ozkan Alan, Faysal Dane, Ilker Nihat Okten, Tugba Akin Telli, Handan Kaya, Nalan Akgul Babacan, Nazım Can Demircan, Perran Fulden Yumuk, Serap Kaya, Mustafa Umit Ugurlu, Bilge Aktas, Tugba Basoglu Tuylu, Rukiye Arikan, Ozlem Ercelep
Publikováno v:
Cancer Research. 80:P2-16
Background: Breast cancer is the most common type of cancer among women in the world. Neoadjuvant chemotherapy is the standard treatment modality in locally advanced disease. Pathological complete response (pCR) is a significant prognostic factor for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61867ce5ebc68b2dd2af320a1ed8982c
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-18
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-18
Autor:
Naziye Ak, Saban Secmeler, Abdilkerim Oyman, Ahmet Kucukarda, Ilker Nihat Okten, Ilkay Gulturk, Ilhan Hacibekiroglu, Deniz Tataroğlu Özyükseler, Okan Avci, Adnan Aydiner, Muhammed Mustafa Atci, Tugba Basoglu, İbrahim Çil, Nail Paksoy, Emre Cakir, Ferhat Ferhatoglu, Arif Hakan Onder, Murat Ayhan, Melike Ozcelik, Baran Akagunduz
Publikováno v:
Tumori. 108(1)
Introduction: Ado-trastuzumab emtansine (T-DM1) is an antibody–drug conjugate and its survival advantage has been shown in advanced human epidermal growth factor receptor 2 (HER2)–positive breast cancer. However, clinical trials underrepresent pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da05515b5f89636d4f45a901f25584dd
https://pubmed.ncbi.nlm.nih.gov/34365852
https://pubmed.ncbi.nlm.nih.gov/34365852
Autor:
Tugba Akin Telli, Handan Kaya, Rahib Hasanov, Nazım Can Demircan, Bilge Aktas, Ozkan Alan, Perran Fulden Yumuk, Tugba Basoglu, Rukiye Arikan, Ozlem Ercelep, Faysal Dane, Mustafa Umit Ugurlu, Ilker Nihat Okten, Sinan Koca, Nalan Akgul Babacan, Serap Kaya
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Purpose Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall survival. Insul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2fc5161086bfa312feb6dc3463c645
https://doi.org/10.1186/s12957-020-02019-y
https://doi.org/10.1186/s12957-020-02019-y
Autor:
Birol, Yildiz, Ahmet, Kucukarda, Ali, Gokyer, Atike, Gokcen Demiray, Semra, Paydas, Ipek, Pinar Aral, Ozge, Gumusay, Ahmet, Bilici, Nadiye, Akdeniz, Aykut, Bahceci, Hacer, Demir, Ece, Esin, Ummugul, Üyeturk, Ilker, Nihat Okten, Ismail, Erturk, Haci Mehmet, Turk, Ulas Serkan, Topaloglu, Tugba, Basoglu, Nazim, Serdar Turhal, Havva, Yesil Cinkir, Serkan, Menekse, Yagmur, Cakmak, Yuksel, Urun, Ramazan, Acar, Engin, Kut, Pinar, Dal, Teoman, Sakalar, Oktay, Halit Aktepe, Nuri, Karadurmus
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(2)
The purpose of this study was to determine whether primary tumor localization may be a risk factor for relapse and survival in seminomatous germ cell tumors (GCT) patients.In our study, 612 seminomatous GCT patients diagnosed in 22 centers between 01
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffa3e8dbc74131326a26cd160fbfd703
https://pubmed.ncbi.nlm.nih.gov/32521916
https://pubmed.ncbi.nlm.nih.gov/32521916
Autor:
Aysenur Toksoz Yildirim, Ilker Nihat Okten, Nazım Can Demircan, Tugba Akin Telli, Rukiye Arikan, Ozlem Ercelep, Ozkan Alan, Perran Fulden Yumuk, Tugba Basoglu Tuylu, Faysal Dane, Tunc Ones
Publikováno v:
Current problems in cancer. 44(5)
Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor originating from endothelial cells. Clinical aspect of the disease covers a wide spectrum from a low-grade tumor to a fatal cancer. Most common sites of EHE are reported as lung, liver a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f07f6fb00658987396eb06e4a0d5b11c
https://pubmed.ncbi.nlm.nih.gov/32201052
https://pubmed.ncbi.nlm.nih.gov/32201052
Autor:
Mahmut Büyükşimşek, Ahmet Dirican, Osman Kostek, Serdar Turhal, Kezban Nur Pilanci, Ulug Mutlu Gunaydin, Atakan Demir, Dogan Uncu, Umut Kefeli, Gokhan Ucar, Ilker Nihat Okten, Ulas Isik, Teoman Sakalar, Semra Paydas, Devrim Cabuk, Altay Aliyev, Kazim Uygun, Gokcen Demiray, Ali Gökyer, Melih Simsek
e16075 Background: Although the distribution in the world varies widely, renal cell carcinoma (RCC) is the ninth most common cancer, especially in males. It’s the seventh most common cancer in Turkey. In this study, the progression-free survival (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb72b889c0e32e0fb3b201c4699de82
https://hdl.handle.net/20.500.12605/9001
https://hdl.handle.net/20.500.12605/9001
